Skip to main content

and
  1. No Access

    Article

    Predictors of hematologic malignancy relapse in patients with advanced chronic graft-versus-host disease

    Malignancy relapse remains a major barrier to treatment success in patients after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Chronic graft-versus-host disease (cGVHD) markedly reduces hema...

    Claire L. Ruben, Filip Pirsl, Seth M. Steinberg in Bone Marrow Transplantation (2021)

  2. No Access

    Article

    Impact of the 2014 NIH chronic graft-versus-host disease scoring criteria modifications assessed in a large cohort of severely affected patients

    In 2005, the National Institutes of Health (NIH) chronic graft-versus-host disease (cGVHD) consensus project provided diagnosis and staging criteria, based mostly on clinical experience and expert opinion. The...

    Ana Zelic Kerep, Jacob Broome, Filip Pirsl, Lauren M. Curtis in Bone Marrow Transplantation (2019)